CanSino Biologics Sees Revenue Surge but Faces Net Losses - TipRanks
CJH Stock | EUR 3.98 0.04 1.02% |
Roughly 55% of CanSino Biologics' stockholders are presently thinking to get in. The analysis of current outlook of investing in CanSino Biologics suggests that some traders are interested regarding CanSino Biologics' prospects. The current market sentiment, together with CanSino Biologics' historical and current headlines, can help investors time the market. In addition, many technical investors use CanSino Biologics stock news signals to limit their universe of possible portfolio assets.
CanSino Biologics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of CanSino daily returns and investor perception about the current price of CanSino Biologics as well as its diversification or hedging effects on your existing portfolios.
CanSino |
CanSino Biologics Sees Revenue Surge but Faces Net Losses TipRanks
Read at news.google.com
CanSino Biologics Fundamental Analysis
We analyze CanSino Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CanSino Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CanSino Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
CanSino Biologics is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
CanSino Biologics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CanSino Biologics stock to make a market-neutral strategy. Peer analysis of CanSino Biologics could also be used in its relative valuation, which is a method of valuing CanSino Biologics by comparing valuation metrics with similar companies.
Peers
CanSino Biologics Related Equities
TOW | Tower Semiconductor | 1.96 | ||||
SMG | Magnachip Semiconductor | 0.52 | ||||
SMG | MagnaChip Semiconductor | 1.55 | ||||
CY9D | Microbot Medical | 2.08 | ||||
8KH | TOREX SEMICONDUCTOR | 3.29 | ||||
51KB | AVITA Medical | 3.97 |
Complementary Tools for CanSino Stock analysis
When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |